Literature DB >> 26945518

The implications of endemic IMP-4 carbapenemase for clinical laboratory susceptibility testing.

Namraj Goire1, Gerald B Harnett1, Lyn C O'Reilly2, Paul R Ingram3, Michael J Leung4, David J Speers5, Paul E Healy1, Timothy J J Inglis4.   

Abstract

A local predominance of carbapenemase producing Enterobacteriaceae with low minimum inhibitory concentrations (MIC) to meropenem prompted a review of methods available for carbapenemase detection. We report on results using two selective media, temocillin discs, CarbaNP test, GeneXpert Carba-R assay and an in-house PCR assay. Crown
Copyright © 2016. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CarbaNP test; Carbapenemase producing Enterobacteriaceae; GeneXpert Carba-R assay

Mesh:

Substances:

Year:  2016        PMID: 26945518     DOI: 10.1016/j.mimet.2016.03.001

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN: 0167-7012            Impact factor:   2.363


  4 in total

1.  Multicenter Evaluation of the Xpert Carba-R Assay for Detection and Identification of Carbapenemase Genes in Sputum Specimens.

Authors:  Zhen Cai; Jia Tao; Tianye Jia; Hongyu Fu; Xin Zhang; Mei Zhao; Hong Du; Hua Yu; Bin Shan; Bin Huang; Liang Chen; Yi-Wei Tang; Wei Jia; Fen Qu
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

Review 2.  Carbapenemase-producing Enterobacteriaceae in animals and methodologies for their detection.

Authors:  Rebecca E V Anderson; Patrick Boerlin
Journal:  Can J Vet Res       Date:  2020-01       Impact factor: 1.310

3.  Rapid susceptibility profiling of carbapenem-resistant Klebsiella pneumoniae.

Authors:  K T Mulroney; J M Hall; X Huang; E Turnbull; N M Bzdyl; A Chakera; U Naseer; E M Corea; M J Ellington; K L Hopkins; A L Wester; O Ekelund; N Woodford; T J J Inglis
Journal:  Sci Rep       Date:  2017-05-15       Impact factor: 4.379

4.  IncN1 ST7 Epidemic Plasmid Carrying blaIMP-4 in One ST85-Type Klebsiella oxytoca Clinical Isolate with Porin Deficiency.

Authors:  Mingyue Sun; Weiqiang Xiao; Qingxia Xu
Journal:  Infect Drug Resist       Date:  2021-09-18       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.